Brendan D. Manning

Citat de

	Toate	Din 2020
Referințe bibliografice	48257	18913
h-index	70	57
i10-index	101	89

4200

2100

1050

3150

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025178 370 547 601 643 1066 1303 1507 1709 2055 2132 2382 2510 2655 2872 3056 3284 3643 4170 3746 3437 3359 553

Acces public

Afișați-le pe toate

69 de articole

5 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Lewis CantleyDana Farber Cancer Center and Harvard Medical SchoolAdresă de e-mail confirmată pe med.cornell.edu
John AsaraAssociate Professor Medicine, Harvard Medical School; Director, Beth Israel Deaconess Medical CenterAdresă de e-mail confirmată pe bidmc.harvard.edu
Issam Ben-SahraNorthwestern UniversityAdresă de e-mail confirmată pe northwestern.edu
Gerta HoxhajUT Southwestern Medical CenterAdresă de e-mail confirmată pe utsouthwestern.edu
David J. KwiatkowskiProfessor of Medicine, Harvard Medical SchoolAdresă de e-mail confirmată pe rics.bwh.harvard.edu
John BlenisProfessor of Pharmacology, Weill Cornell MedicineAdresă de e-mail confirmată pe med.cornell.edu
Andrew TeeProfessor of Cancer and GeneticsAdresă de e-mail confirmată pe cardiff.ac.uk
Mustafa SahinBoston Children's Hospital; Harvard Medical SchoolAdresă de e-mail confirmată pe childrens.harvard.edu
Reuben ShawThe Salk Institute of Biological StudiesAdresă de e-mail confirmată pe salk.edu
Clary ClishSenior Director, Metabolomics, Broad Institute of MIT and HarvardAdresă de e-mail confirmată pe broadinstitute.org
James MitchellAssociate Professor of Genetics and Complex Diseases, Harvard T. H. Chan School of Public HealthAdresă de e-mail confirmată pe hsph.harvard.edu
Michael MacArthurPrinceton UniversityAdresă de e-mail confirmată pe princeton.edu
Michael SnyderStanford UniversityAdresă de e-mail confirmată pe stanford.edu
Alex TokerAdresă de e-mail confirmată pe bidmc.harvard.edu
George TalbottVerndari IncAdresă de e-mail confirmată pe verndariinc.com
Elizabeth P HenskeProfessor of Medicine, Harvard Medical SchoolAdresă de e-mail confirmată pe bwh.harvard.edu
Benjamin HousdenLiving Systems Institute, University of ExeterAdresă de e-mail confirmată pe exeter.ac.uk
Chin-Lee WuMassachusetts General HospitalAdresă de e-mail confirmată pe mgh.harvard.edu
Pichai RamanBioinformatics Leader at Spark TherapeuticsAdresă de e-mail confirmată pe sparktx.com
Anthony J. Covarrubias, PhDAssistant Professor. UCLA David Geffen School of Medicine and Division of Life SciencesAdresă de e-mail confirmată pe mednet.ucla.edu

Urmăriți

Brendan D. Manning

Harvard University

Adresă de e-mail confirmată pe hsph.harvard.edu - Pagina de pornire

Signaling Metabolism Tumors


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
AKT/PKB signaling: navigating downstream BD Manning, LC Cantley Cell 129 (7), 1261-1274, 2007	7568	2007
AKT/PKB signaling: navigating the network BD Manning, A Toker Cell 169 (3), 381-405, 2017	3580	2017
Activation of a metabolic gene regulatory network downstream of mTOR complex 1 K Düvel, JL Yecies, S Menon, P Raman, AI Lipovsky, AL Souza, ... Molecular cell 39 (2), 171-183, 2010	2359	2010
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway BD Manning, AR Tee, MN Logsdon, J Blenis, LC Cantley Molecular cell 10 (1), 151-162, 2002	1962	2002
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex J Brugarolas, K Lei, RL Hurley, BD Manning, JH Reiling, E Hafen, ... Genes & development 18 (23), 2893-2904, 2004	1724	2004
Targeting the PI3K-Akt pathway in human cancer: rationale and promise J Luo, BD Manning, LC Cantley Cancer cell 4 (4), 257-262, 2003	1712	2003
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism G Hoxhaj, BD Manning Nature Reviews Cancer 20 (2), 74-88, 2020	1635	2020
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb AR Tee, BD Manning, PP Roux, LC Cantley, J Blenis Current biology 13 (15), 1259-1268, 2003	1546	2003
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth J Huang, BD Manning Biochemical Journal 412 (2), 179-190, 2008	1505	2008
The LKB1 tumor suppressor negatively regulates mTOR signaling RJ Shaw, N Bardeesy, BD Manning, L Lopez, M Kosmatka, RA DePinho, ... Cancer cell 6 (1), 91-99, 2004	1287	2004
Tuberous sclerosis complex-1 and-2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling AR Tee, DC Fingar, BD Manning, DJ Kwiatkowski, LC Cantley, J Blenis Proceedings of the National Academy of Sciences 99 (21), 13571-13576, 2002	1044	2002
A complex interplay between Akt, TSC2 and the two mTOR complexes J Huang, BD Manning Biochemical Society Transactions 37 (1), 217-222, 2009	922	2009
Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome S Menon, CC Dibble, G Talbott, G Hoxhaj, AJ Valvezan, H Takahashi, ... Cell 156 (4), 771-785, 2014	891	2014
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1 I Ben-Sahra, JJ Howell, JM Asara, BD Manning Science 339 (6125), 1323-1328, 2013	851	2013
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle I Ben-Sahra, G Hoxhaj, SJH Ricoult, JM Asara, BD Manning Science 351 (6274), 728-733, 2016	825	2016
Signal integration by mTORC1 coordinates nutrient input with biosynthetic output CC Dibble, BD Manning Nature cell biology 15 (6), 555-564, 2013	822	2013
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo WE Dowdle, B Nyfeler, J Nagel, RA Elling, S Liu, E Triantafellow, ... Nature cell biology 16 (11), 1069-1079, 2014	727	2014
TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1 CC Dibble, W Elis, S Menon, W Qin, J Klekota, JM Asara, PM Finan, ... Molecular cell 47 (4), 535-546, 2012	711	2012
Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways JL Yecies, HH Zhang, S Menon, S Liu, D Yecies, AI Lipovsky, C Gorgun, ... Cell metabolism 14 (1), 21-32, 2011	709	2011
The TSC1-TSC2 complex is required for proper activation of mTOR complex 2 J Huang, CC Dibble, M Matsuzaki, BD Manning Molecular and cellular biology 28 (12), 4104-4115, 2008	665	2008

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori